Back
ESC Premium Access

The predictors of the efficacy of pharmacological cardioversion with class III antiarrhythmic drug - nibentan in patients with persistent atrial fibrillation

Session: Poster session 7 - Electrocardiography + cardioversion
Topic: Electrocardiography
Speaker: Doctor I. Bregvadze (Tbilisi, GE)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Ina Bregvadze

The Center of Vascular and Heart Diseases, Tbilisi (Georgia)
0 follower

29 more presentations in this session

The CHA2DS2-VASc - score and sex as predictors of thromboembolic complications in cardioversion of acute atrial fibrillation.

Speaker: Ms A. Bah (Kuopio, FI)

Access
Abstract
Like
Thumbnail

Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study

Speaker: Professor J. Merino (Madrid, ES)

Access
Abstract
Like
Thumbnail

Specific ECG signs of LMNA-associated dilated cardiomyopathy

Speaker: Doctor T. Vaikhanskaya (Minsk, BY)

Access
Abstract
Slides
Like
Thumbnail

Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study

Speaker: Doctor A. Dan (Bucharest, RO)

Access
Abstract
Slides
Like
Thumbnail

Prevalence and prognostic significance of negative U-waves in the 12-lead electrocardiogram in the general population

Speaker: Doctor A. Holkeri (Lahti, FI)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 7 - Electrocardiography + cardioversion

Speakers: Doctor I. Bregvadze, Ms A. Bah, Professor J. Merino, Doctor T. Vaikhanskaya, Doctor A. Dan...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources